Immediate Impact

2 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
2024 Standout
1 intermediate paper

Works of Kai Breuer being referenced

Non-Hodgkin’s Lymphoma After Primary Hodgkin’s Disease in the German Hodgkin’s Lymphoma Study Group: Incidence, Treatment, and Prognosis
2001

Author Peers

Author Last Decade Papers Cites
Kai Breuer 198 196 250 12 502
D. Parker 59 113 182 20 542
Indra Thielen 210 197 137 9 420
Rizvan Bush 187 113 92 17 480
F. B. Hagemeister 296 325 45 22 553
Dorothy Pearson 53 84 125 12 536
Renaldo Guzmán 250 308 84 20 476
Dianne M. Howser 158 175 39 12 490
Austin Df 29 107 223 12 418
Peter Svenssen Munksgaard 114 85 33 10 497
Laura Bellio 99 184 52 15 495

All Works

Loading papers...

Rankless by CCL
2026